Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about XNYS:NNVC

Recent news which mentions XNYS:NNVC

NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
Tickers AZN GSK PFE SNY
Tags XNYS:NNVC NanoViricides, Inc/
From TheNewswire.com - RSS (Media)
NanoViricides progressing well with new Covid study
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
Tickers GILD MRK PFE
Tags NanoViricides, Inc/ XNYS:NNVC
From TheNewswire.com - RSS (Media)
NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
Tags XNYS:NNVC NanoViricides
From TheNewswire.com - RSS (Media)
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Tickers GILD MRK PFE
Tags XNYS:NNVC NanoViricides, Inc/
From TheNewswire.com - RSS (Media)
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
Tickers GILD MRK PFE
Tags NanoViricides, Inc/ XNYS:NNVC
From TheNewswire.com - RSS (Media)
NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
NanoViricides using unique technology platform to fight against viruses
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Tickers AZN GILD MRK MRNA
Tags XNYS:NNVC NanoViricides, Inc/
From TheNewswire.com - RSS (Media)
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Tickers GILD MRK MRNA NVAX
Tags XNYS:NNVC NanoViricides, Inc/
From TheNewswire.com - RSS (Media)
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
Tickers NNVC
Tags NanoViricides, Inc/ XNYS:NNVC
From TheNewswire.com - RSS (Media)
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Tickers NNVC
Tags NanoViricides, Inc/ XNYS:NNVC
From TheNewswire.com - RSS (Media)
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
Tickers CTLT GILD SIGA
Tags NanoViricides, Inc/ XNYS:NNVC
From TheNewswire.com - RSS (Media)
Monkeypox Is Popping Up In Places It Shouldn’t But NanoViricides Says It May Have A Solution
Tickers SIGA
Tags NanoViricides, Inc/ XNYS:NNVC
From TheNewswire.com - RSS (Media)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.